At the risk of seeming bipolar, I only posted this an example of what can happen when big pharma sees value in mAb's. As an example, a NASH deal could be mind blowing huge.

My biggest concern about NP is the utter lack of experience in formulating a deal of this magnitude if it is even possible. And big pharma has boiler plate contracts written by the best lawyers money can buy in the pharma industry. He would need some heavy duty help on a deal like that.

These are problems to have and worry about. But his (NP) track record of promises is legendary. The struggle is real.